Disclosures for "Exposure-Response Modeling to Describe Change in Brain Amyloid Following Lecanemab Administration in Patients with Early Alzheimer’s Disease"
-
-
Ziad Hussein has nothing to disclose.
-
-
Mr. Takenaka has nothing to disclose.
-
-
-
Larisa Reyderman has nothing to disclose.